{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:19:26Z","timestamp":1789705166037,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001469","name":"Singapore General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ijantimicag.2024.107410","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T17:44:03Z","timestamp":1734630243000},"page":"107410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Individualized antimicrobial therapy using antibiotic combination testing and therapeutic drug monitoring to treat carbapenem-resistant Acintobacter baumannii infection"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-300X","authenticated-orcid":false,"given":"Nathalie Grace Sy","family":"Chua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin Kau-Kiat","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze Peng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3125-739X","authenticated-orcid":false,"given":"Sarah Silin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7321-710X","authenticated-orcid":false,"given":"Candice Yuen Yue","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-4411","authenticated-orcid":false,"given":"Andrea Layhoon","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.ijantimicag.2024.107410_bib0001","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/ofid\/ofy293","article-title":"Antimicrobial susceptibility of Acinetobacter calcoaceticus\u2013Acinetobacter baumannii complex and Stenotrophomonas maltophilia clinical isolates: results from the SENTRY Antimicrobial Surveillance Program (1997\u20132016)","volume":"6","author":"Gales","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijantimicag.2024.107410_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00042-16","article-title":"Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia","volume":"30","author":"Hsu","year":"2017","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107410_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijantimicag.2024.107410_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158740","article-title":"From Bench-Top to Bedside: a Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)","volume":"11","author":"Cai","year":"2016","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.ijantimicag.2024.107410_bib0005","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ajhp\/zxaa128","article-title":"Towards precision medicine: therapeutic drug monitoring-guided dosing of vancomycin and \u03b2-lactam antibiotics to maximize effectiveness and minimize toxicity","volume":"77","author":"Cusumano","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107410_bib0006","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/antibiotics11010054","article-title":"Quantification of Fosfomycin in combination with nine antibiotics in human plasma and cation-adjusted Mueller-Hinton ii broth via LCMS","volume":"11","author":"Goh","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"9","key":"10.1016\/j.ijantimicag.2024.107410_bib0007","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1093\/jac\/dkw187","article-title":"Pharmacokinetics and total removal of fosfomycin in two patients undergoing intermittent haemodialysis and extended dialysis: prescription needs to avoid under-dosing","volume":"71","author":"Schmidt","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2024.107410_bib0008","unstructured":"Aztreonam. Lexi-Drugs. UpToDate. Waltham, MA. Available at: https:\/\/online.lexi.com. [updated 2023 Jun 26; cited 2023 Jun 26]"},{"issue":"11","key":"10.1016\/j.ijantimicag.2024.107410_bib0009","doi-asserted-by":"crossref","first-page":"e01066","DOI":"10.1128\/AAC.01066-18","article-title":"Simplified aztreonam dosing in patients with end-stage renal disease: results of a Monte Carlo simulation","volume":"62","author":"Gross","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ijantimicag.2024.107410_bib0010","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/AAC.00180-09","article-title":"Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid or vancomycin in an in vitro pharmacodynamic model","volume":"53","author":"LaPlante","year":"2009","journal-title":"Antimicrobial Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijantimicag.2024.107410_bib0011","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00228-023-03477-5","article-title":"Population plasma and urine pharmacokinetics and the probability of target attainment of fosfomycin in healthy male volunteers","volume":"79","author":"Edwina","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.ijantimicag.2024.107410_bib0012","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1093\/jac\/dkw231","article-title":"A review of the pharmacokinetics and pharmacodynamics of aztreonam","volume":"71","author":"Ramsey","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ijantimicag.2024.107410_bib0013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/antibiotics6040024","article-title":"Fosfomycin: pharmacological, clinical and future perspectives","volume":"6","author":"Dijkmans","year":"2017","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2024.107410_bib0014","unstructured":"European medicines agency completes review of polymyxin-based medicines recommendations issued for safe use in patients with serious infections resistant to standard antibiotics. 2014. [(accessed on 3 May 2024)]. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/polymyxin-article-31-referral-european-medicines-agency-completes-review-polymyxin-based-medicines_en.pdf"},{"key":"10.1016\/j.ijantimicag.2024.107410_bib0015","unstructured":"Cefepime. Lexi-Drugs. UpToDate. Waltham, MA. Available at: https:\/\/online.lexi.com. [updated 2023 Jun 26; cited 2023 Jun 26]"},{"issue":"6","key":"10.1016\/j.ijantimicag.2024.107410_bib0016","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/AAC.47.6.1853-1861.2003","article-title":"Pharmacokinetics and pharmacodynamics of cefepime in patients with various degress of renal function","volume":"47","author":"Tam","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107410_bib0017","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FTD.0000000000000675","article-title":"Meropenem, cefepime, and piperacillin protein binding in patient samples","volume":"42","author":"Al-Shaer","year":"2020","journal-title":"Ther Drug Monit"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107410_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic Parameters: rationale for Antibacterial Dosing of Mice and Men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2024.107410_bib0019","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne","year":"2017","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.ijantimicag.2024.107410_bib0020","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.1984.174","article-title":"Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics","volume":"26","author":"Gerig","year":"1984","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2024.107410_bib0021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40360-016-0048-y","article-title":"Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study","volume":"17","author":"Descombes","year":"2016","journal-title":"BMC Pharmacol Toxicol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924003261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857924003261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:46:16Z","timestamp":1738086376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857924003261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0924857924003261"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107410","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individualized antimicrobial therapy using antibiotic combination testing and therapeutic drug monitoring to treat carbapenem-resistant Acintobacter baumannii infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107410"}}